Dexamethasone suppression test in patients with Parkinson's disease
Identifieur interne : 003790 ( Istex/Corpus ); précédent : 003789; suivant : 003791Dexamethasone suppression test in patients with Parkinson's disease
Auteurs : Kostić ; Nadežda Ovi Kovi Erni ; Ljiljana Besla Umbaširevi ; Gordana Oci ; Dragan Pavlovi ; Milisav NikoliSource :
- Movement Disorders [ 0885-3185 ] ; 1990.
English descriptors
Abstract
The Dexamethasone Suppression Test (DST), supposed to effectively distinguish between endogenous and nonendogenous depression, was performed in a group of 34 patients with Parkinson's disease. Abnormal DST results were observed in 50% of the patients. The patients were clinically divided into subgroups of depressed and nondepressed parkinsonians. Abnormal DST results were significantly more frequent in depressed (75%) than in nondepressed parkinsonians (27.7%).
Url:
DOI: 10.1002/mds.870050106
Links to Exploration step
ISTEX:A5565DDDE3133C16F29CDC068A90E86D62965143Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dexamethasone suppression test in patients with Parkinson's disease</title><author><name sortKey="Kosti" sort="Kosti" uniqKey="Kosti" last="Kosti">Kostić</name><affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation></affiliation></author><author><name sortKey=" Ovi Kovi Erni, Nadezda" sort=" Ovi Kovi Erni, Nadezda" uniqKey=" Ovi Kovi Erni N" first="Nadežda" last=" Ovi Kovi Erni">Nadežda Ovi Kovi Erni</name><affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation></affiliation></author><author><name sortKey="Besla Umbasirevi, Ljiljana" sort="Besla Umbasirevi, Ljiljana" uniqKey="Besla Umbasirevi L" first="Ljiljana" last="Besla Umbaširevi">Ljiljana Besla Umbaširevi</name><affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation></affiliation></author><author><name sortKey="Oci, Gordana" sort="Oci, Gordana" uniqKey="Oci G" first="Gordana" last="Oci">Gordana Oci</name><affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation></affiliation></author><author><name sortKey="Pavlovi, Dragan" sort="Pavlovi, Dragan" uniqKey="Pavlovi D" first="Dragan" last="Pavlovi">Dragan Pavlovi</name><affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation></affiliation></author><author><name sortKey="Nikoli, Milisav" sort="Nikoli, Milisav" uniqKey="Nikoli M" first="Milisav" last="Nikoli">Milisav Nikoli</name><affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A5565DDDE3133C16F29CDC068A90E86D62965143</idno><date when="1990" year="1990">1990</date><idno type="doi">10.1002/mds.870050106</idno><idno type="url">https://api.istex.fr/document/A5565DDDE3133C16F29CDC068A90E86D62965143/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003790</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Dexamethasone suppression test in patients with Parkinson's disease</title><author><name sortKey="Kosti" sort="Kosti" uniqKey="Kosti" last="Kosti">Kostić</name><affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation></affiliation></author><author><name sortKey=" Ovi Kovi Erni, Nadezda" sort=" Ovi Kovi Erni, Nadezda" uniqKey=" Ovi Kovi Erni N" first="Nadežda" last=" Ovi Kovi Erni">Nadežda Ovi Kovi Erni</name><affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation></affiliation></author><author><name sortKey="Besla Umbasirevi, Ljiljana" sort="Besla Umbasirevi, Ljiljana" uniqKey="Besla Umbasirevi L" first="Ljiljana" last="Besla Umbaširevi">Ljiljana Besla Umbaširevi</name><affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation></affiliation></author><author><name sortKey="Oci, Gordana" sort="Oci, Gordana" uniqKey="Oci G" first="Gordana" last="Oci">Gordana Oci</name><affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation></affiliation></author><author><name sortKey="Pavlovi, Dragan" sort="Pavlovi, Dragan" uniqKey="Pavlovi D" first="Dragan" last="Pavlovi">Dragan Pavlovi</name><affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation></affiliation></author><author><name sortKey="Nikoli, Milisav" sort="Nikoli, Milisav" uniqKey="Nikoli M" first="Milisav" last="Nikoli">Milisav Nikoli</name><affiliation><mods:affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1990">1990</date><biblScope unit="vol">5</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="23">23</biblScope><biblScope unit="page" to="26">26</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">A5565DDDE3133C16F29CDC068A90E86D62965143</idno><idno type="DOI">10.1002/mds.870050106</idno><idno type="ArticleID">MDS870050106</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dexamethasone suppression test</term><term>Parkinson's disease</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The Dexamethasone Suppression Test (DST), supposed to effectively distinguish between endogenous and nonendogenous depression, was performed in a group of 34 patients with Parkinson's disease. Abnormal DST results were observed in 50% of the patients. The patients were clinically divided into subgroups of depressed and nondepressed parkinsonians. Abnormal DST results were significantly more frequent in depressed (75%) than in nondepressed parkinsonians (27.7%).</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Dr. Kostić</name><affiliations><json:string>Clinic for Neurology CCMF, Belgrade, Yugoslavia</json:string></affiliations></json:item><json:item><name>Nadežda Čovičković‐Šternić</name><affiliations><json:string>Clinic for Neurology CCMF, Belgrade, Yugoslavia</json:string></affiliations></json:item><json:item><name>Ljiljana Beslać‐Bumbaširević</name><affiliations><json:string>Clinic for Neurology CCMF, Belgrade, Yugoslavia</json:string></affiliations></json:item><json:item><name>Gordana Ocić</name><affiliations><json:string>Clinic for Neurology CCMF, Belgrade, Yugoslavia</json:string></affiliations></json:item><json:item><name>Dragan Pavlović</name><affiliations><json:string>Clinic for Neurology CCMF, Belgrade, Yugoslavia</json:string></affiliations></json:item><json:item><name>Milisav Nikolić</name><affiliations><json:string>Clinic for Neurology CCMF, Belgrade, Yugoslavia</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Dexamethasone suppression test</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Parkinson's disease</value></json:item></subject><language><json:string>eng</json:string></language><abstract>The Dexamethasone Suppression Test (DST), supposed to effectively distinguish between endogenous and nonendogenous depression, was performed in a group of 34 patients with Parkinson's disease. Abnormal DST results were observed in 50% of the patients. The patients were clinically divided into subgroups of depressed and nondepressed parkinsonians. Abnormal DST results were significantly more frequent in depressed (75%) than in nondepressed parkinsonians (27.7%).</abstract><qualityIndicators><score>2.687</score><pdfVersion>1.3</pdfVersion><pdfPageSize>576 x 828 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>465</abstractCharCount><pdfWordCount>1943</pdfWordCount><pdfCharCount>12626</pdfCharCount><pdfPageCount>4</pdfPageCount><abstractWordCount>62</abstractWordCount></qualityIndicators><title>Dexamethasone suppression test in patients with Parkinson's disease</title><genre><json:string>Serial article</json:string></genre><host><volume>5</volume><pages><total>4</total><last>26</last><first>23</first></pages><issn><json:string>0885-3185</json:string></issn><issue>1</issue><subject><json:item><value>Article</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>1990</publicationDate><copyrightDate>1990</copyrightDate><doi><json:string>10.1002/mds.870050106</json:string></doi><id>A5565DDDE3133C16F29CDC068A90E86D62965143</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/A5565DDDE3133C16F29CDC068A90E86D62965143/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/A5565DDDE3133C16F29CDC068A90E86D62965143/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/A5565DDDE3133C16F29CDC068A90E86D62965143/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Dexamethasone suppression test in patients with Parkinson's disease</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>Wiley Subscription Services, Inc., A Wiley Company</p></availability><date>1990</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Dexamethasone suppression test in patients with Parkinson's disease</title><author><persName><surname>Kostić</surname><roleName type="degree">Dr.</roleName></persName><note type="correspondence"><p>Correspondence: Neurološka klinika KCMF, ul. Dr Subotića 6, 11000 Belgrade, Yugoslavia</p></note><affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation></author><author><persName><forename type="first">Nadežda</forename><surname>Čovičković‐Šternić</surname></persName><affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation></author><author><persName><forename type="first">Ljiljana</forename><surname>Beslać‐Bumbaširević</surname></persName><affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation></author><author><persName><forename type="first">Gordana</forename><surname>Ocić</surname></persName><affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation></author><author><persName><forename type="first">Dragan</forename><surname>Pavlović</surname></persName><affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation></author><author><persName><forename type="first">Milisav</forename><surname>Nikolić</surname></persName><affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1990"></date><biblScope unit="vol">5</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="23">23</biblScope><biblScope unit="page" to="26">26</biblScope></imprint></monogr><idno type="istex">A5565DDDE3133C16F29CDC068A90E86D62965143</idno><idno type="DOI">10.1002/mds.870050106</idno><idno type="ArticleID">MDS870050106</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1990</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>The Dexamethasone Suppression Test (DST), supposed to effectively distinguish between endogenous and nonendogenous depression, was performed in a group of 34 patients with Parkinson's disease. Abnormal DST results were observed in 50% of the patients. The patients were clinically divided into subgroups of depressed and nondepressed parkinsonians. Abnormal DST results were significantly more frequent in depressed (75%) than in nondepressed parkinsonians (27.7%).</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>Dexamethasone suppression test</term></item><item><term>Parkinson's disease</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Article</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1990">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/A5565DDDE3133C16F29CDC068A90E86D62965143/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="subtitle">Official Journal of the Movement Disorder Society</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="10"><doi origin="wiley" registered="yes">10.1002/mds.v5:1</doi><numberingGroup><numbering type="journalVolume" number="5">5</numbering><numbering type="journalIssue">1</numbering></numberingGroup><coverDate startDate="1990">1990</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="6" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.870050106</doi><idGroup><id type="unit" value="MDS870050106"></id></idGroup><countGroup><count type="pageTotal" number="4"></count></countGroup><titleGroup><title type="articleCategory">Article</title><title type="tocHeading1">Articles</title></titleGroup><copyright ownership="thirdParty">Copyright © 1990 Movement Disorder Society</copyright><eventGroup><event type="firstOnline" date="2004-10-12"></event><event type="publishedOnlineFinalForm" date="2004-10-12"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-09"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">23</numbering><numbering type="pageLast">26</numbering></numberingGroup><correspondenceTo>Neurološka klinika KCMF, ul. Dr Subotića 6, 11000 Belgrade, Yugoslavia</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS870050106.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="2"></count><count type="referenceTotal" number="28"></count></countGroup><titleGroup><title type="main" xml:lang="en">Dexamethasone suppression test in patients with Parkinson's disease</title><title type="short" xml:lang="en">DST IN PARKINSON'S DISEASE</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><honorifics>Dr.</honorifics><givenNames>Vladimir S.</givenNames><familyName>Kostić</familyName></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Nadežda</givenNames><familyName>Čovičković‐Šternić</familyName></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Ljiljana</givenNames><familyName>Beslać‐Bumbaširević</familyName></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Gordana</givenNames><familyName>Ocić</familyName></personName></creator><creator xml:id="au5" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Dragan</givenNames><familyName>Pavlović</familyName></personName></creator><creator xml:id="au6" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Milisav</givenNames><familyName>Nikolić</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="RS" type="organization"><unparsedAffiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">Dexamethasone suppression test</keyword><keyword xml:id="kwd2">Parkinson's disease</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>The Dexamethasone Suppression Test (DST), supposed to effectively distinguish between endogenous and nonendogenous depression, was performed in a group of 34 patients with Parkinson's disease. Abnormal DST results were observed in 50% of the patients. The patients were clinically divided into subgroups of depressed and nondepressed parkinsonians. Abnormal DST results were significantly more frequent in depressed (75%) than in nondepressed parkinsonians (27.7%).</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 4-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Dexamethasone suppression test in patients with Parkinson's disease</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>DST IN PARKINSON'S DISEASE</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Dexamethasone suppression test in patients with Parkinson's disease</title></titleInfo><name type="personal"><namePart type="termsOfAddress">Dr.</namePart><namePart type="family">Kostić</namePart><affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation><description>Correspondence: Neurološka klinika KCMF, ul. Dr Subotića 6, 11000 Belgrade, Yugoslavia</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Nadežda</namePart><namePart type="family">Čovičković‐Šternić</namePart><affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Ljiljana</namePart><namePart type="family">Beslać‐Bumbaširević</namePart><affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Gordana</namePart><namePart type="family">Ocić</namePart><affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Dragan</namePart><namePart type="family">Pavlović</namePart><affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Milisav</namePart><namePart type="family">Nikolić</namePart><affiliation>Clinic for Neurology CCMF, Belgrade, Yugoslavia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">article</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">1990</dateIssued><copyrightDate encoding="w3cdtf">1990</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="tables">2</extent><extent unit="references">28</extent></physicalDescription><abstract lang="en">The Dexamethasone Suppression Test (DST), supposed to effectively distinguish between endogenous and nonendogenous depression, was performed in a group of 34 patients with Parkinson's disease. Abnormal DST results were observed in 50% of the patients. The patients were clinically divided into subgroups of depressed and nondepressed parkinsonians. Abnormal DST results were significantly more frequent in depressed (75%) than in nondepressed parkinsonians (27.7%).</abstract><subject lang="en"><genre>Keywords</genre><topic>Dexamethasone suppression test</topic><topic>Parkinson's disease</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title><subTitle>Official Journal of the Movement Disorder Society</subTitle></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><subject><genre>article category</genre><topic>Article</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>5</number></detail><detail type="issue"><caption>no.</caption><number>1</number></detail><extent unit="pages"><start>23</start><end>26</end><total>4</total></extent></part></relatedItem><identifier type="istex">A5565DDDE3133C16F29CDC068A90E86D62965143</identifier><identifier type="DOI">10.1002/mds.870050106</identifier><identifier type="ArticleID">MDS870050106</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 1990 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003790 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 003790 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:A5565DDDE3133C16F29CDC068A90E86D62965143
|texte= Dexamethasone suppression test in patients with Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |